Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients
- 1 January 1999
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 106 (1) , 148-153
- https://doi.org/10.1016/s0161-6420(99)90021-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- AtovaquoneDrugs, 1995
- Examination of some factors responsible for a food‐induced increase in absorption of atovaquone.British Journal of Clinical Pharmacology, 1994
- Therapy for Ocular ToxoplasmosisAmerican Journal of Ophthalmology, 1993
- Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDSThe Lancet, 1992
- In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1992
- Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondiiThe Journal of Infectious Diseases, 1991
- Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1991
- Clindamycin in the Treatment of Toxoplasmic RetinochoroiditisAmerican Journal of Ophthalmology, 1983
- Variations in Recurrent Active Toxoplasmic RetinochoroiditisArchives of Ophthalmology (1950), 1969
- Therapy of Toxoplasmosis UveitisAmerican Journal of Ophthalmology, 1965